The value of knowing is not always positive

An interesting article by Ciancio et al. (2025) which examines the impact of learning one has HIV when no treatment is available. When there is no treatment available for a life-threatening disease, providing personal health information could lead to despair or fatalistic behaviors resulting in negative health outcomes. We document this possibility utilizing an experiment…

Read More

The Promise and Peril of Price Transparency Under Trump’s New Executive Order

President Donald Trump’s latest executive order aims to strengthen enforcement for CMS’ price transparency requirements. Some experts think greater price transparency could reduce healthcare costs by fostering more competition, while others are concerned about the potential effects on hospital-payer negotiations, as well as the practicality of enforcing these requirements. The post The Promise and Peril…

Read More

BridgeBio Oncology to Go Public in SPAC Deal Bringing $450M+ for Trio of Cancer Drugs

Clinical-stage BridgeBio Oncology Therapeutics, whose financial backers include Cormorant Asset Management, is going public by merging with a Cormorant-sponsored SPAC. The combined company will continue developing drugs targeting various forms of mutated KRAS proteins that drive cancers. The post BridgeBio Oncology to Go Public in SPAC Deal Bringing $450M+ for Trio of Cancer Drugs appeared…

Read More